Menu
Welcome to edition 367 of Insider Weekends. Insider buying increased last week with insiders buying $39.36 million of stock compared to $32.53 million in the week prior. Selling declined with insiders selling $638.73 million of stock last week compared to $716.41 million in the week prior. We are at a seasonally quiet period for insider transactions and so activity is likely to remain muted for a couple of weeks.
Sell/Buy Ratio: The insider Sell/Buy ratio is calculated by dividing the total insider sales in a given week by total insider purchases that week. The adjusted ratio for last week dropped to 16.23. In other words, insiders sold more than 16 times as much stock as they purchased. The Sell/Buy ratio this week compares favorably with the prior week, when the ratio stood at 22.02.
Note: As mentioned in the first post in this series, certain industries have their preferred metrics such as same store sales for retailers, funds from operations (FFO) for REITs and revenue per available room (RevPAR) for hotels that provide a better basis for comparison than simple valuation metrics. However metrics like Price/Earnings, Price/Sales and Enterprise Value/EBITDA included below should provide a good starting point for analyzing the majority of stocks.
Notable Insider Buys:
1. Selecta Biosciences (SELB): $0
Director Timothy A. Springer acquired 338,791 shares of this clinical-stage biopharmaceutical company, paying $17.71 per share for a total amount of $5.99 million. Mr. Springer increased his stake by 2,038.21% to 355,413 shares with this purchase.